Top Midday Gainers

MT Newswires Live

Yesterday

Inhibrx Biosciences (INBX) reported late Thursday its registrational study of ozekibart met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival compared with placebo in patients with advanced or metastatic, unresectable chondrosarcoma.

Shares of Inhibrx almost doubled as intraday trading volume catapulted to over 4.9 million from a daily average of about 151,000.

Comfort Systems USA (FIX) reported late Thursday a year-over-year growth in Q3 earnings and sales.

Its shares jumped 17%, with intraday trading volume at over 701,000 compared with a daily average of about 408,000.

MidWestOne Financial Group's (MOFG) shares jumped 33% after the bank posted an increase overnight in Q3 adjusted earnings.

Intraday trading volume advanced to more than 1.2 million shares from a daily average of about 124,000.

Price: 56.07, Change: +27.71, Percent Change: +97.71

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2578370541"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2578370541\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2578370541?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-25 01:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2578370541","market":"us","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/INBX\">Inhibrx Biosciences</a> (INBX) reported late Thursday its registrational study of ozekibart met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival compared with placebo in patients with advanced or metastatic, unresectable chondrosarcoma.</p><p>Shares of Inhibrx almost doubled as intraday trading volume catapulted to over 4.9 million from a daily average of about 151,000.</p><p>Comfort Systems USA (FIX) reported late Thursday a year-over-year growth in Q3 earnings and sales.</p><p>Its shares jumped 17%, with intraday trading volume at over 701,000 compared with a daily average of about 408,000.</p><p><a href=\"https://laohu8.com/S/MOFG\">MidWestOne Financial Group</a>'s (MOFG) shares jumped 33% after the bank posted an increase overnight in Q3 adjusted earnings.</p><p>Intraday trading volume advanced to more than 1.2 million shares from a daily average of about 124,000.</p><p>Price: 56.07, Change: +27.71, Percent Change: +97.71</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-25 01:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/INBX\">Inhibrx Biosciences</a> (INBX) reported late Thursday its registrational study of ozekibart met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival compared with placebo in patients with advanced or metastatic, unresectable chondrosarcoma.</p><p>Shares of Inhibrx almost doubled as intraday trading volume catapulted to over 4.9 million from a daily average of about 151,000.</p><p>Comfort Systems USA (FIX) reported late Thursday a year-over-year growth in Q3 earnings and sales.</p><p>Its shares jumped 17%, with intraday trading volume at over 701,000 compared with a daily average of about 408,000.</p><p><a href=\"https://laohu8.com/S/MOFG\">MidWestOne Financial Group</a>'s (MOFG) shares jumped 33% after the bank posted an increase overnight in Q3 adjusted earnings.</p><p>Intraday trading volume advanced to more than 1.2 million shares from a daily average of about 124,000.</p><p>Price: 56.07, Change: +27.71, Percent Change: +97.71</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0963586101.USD","symbol_name":"ALLIANZ GLOBAL SMALL CAP EQUITY \"AT\" ACC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2578370541","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2578370541","pubTimestamp":1761327737,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Inhibrx Biosciences (INBX) reported late Thursday its registrational study of ozekibart met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progressi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0963586101.USD":"ALLIANZ GLOBAL SMALL CAP EQUITY \"AT\" ACC","MOFG":"MidWestOne Financial Group","INBX":"Inhibrx Biosciences","LU0054578231.USD":"BGF SYSTEMATIC SUSTAINABLE GLOBAL SMALLCAP \"A2\" (USD) ACC","BK4129":"建筑与工程","BK4139":"生物科技","BK4211":"区域性银行","LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)","BK4567":"ESG概念","FIX":"美国舒适系统"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FIX":1,"INBX":1,"MOFG":1},"content_text":"Inhibrx Biosciences (INBX) reported late Thursday its registrational study of ozekibart met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival compared with placebo in patients with advanced or metastatic, unresectable chondrosarcoma.Shares of Inhibrx almost doubled as intraday trading volume catapulted to over 4.9 million from a daily average of about 151,000.Comfort Systems USA (FIX) reported late Thursday a year-over-year growth in Q3 earnings and sales.Its shares jumped 17%, with intraday trading volume at over 701,000 compared with a daily average of about 408,000.MidWestOne Financial Group's (MOFG) shares jumped 33% after the bank posted an increase overnight in Q3 adjusted earnings.Intraday trading volume advanced to more than 1.2 million shares from a daily average of about 124,000.Price: 56.07, Change: +27.71, Percent Change: +97.71","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}